Published On Mar 21, 2024
0:00 Introduction
01:00 Chris’ background and career to date
02:10 What is the Enigma Project?
04:48 How is genetics being applied to drug discovery today and how does proteomics fit in?
09:23 When the UKBiobank Pharma Proteomics Project began and how long it took to set up
10:57 54k UK Biobank participants tested - discussion of findings
14:33 The project has carried out GWAS on nearly 3k proteins
15:18 Are there plans to scale the project and what do the team hope to discover through larger scale work?
18:10 Which areas of biology has the project provided a good insight into and which have proved more challenging
19:30 Are there projects of a similar scale where it would be possible to focus more on neuroscience?
21:31 Is reaching numbers akin to 100 million whole genomes required to fully leverage genetic data in drug discovery?
25:00 Causal or correlated? Medelian randomisation as an important tool for drawing the link from gene to protein and identifying relevant phenotypes
27:12 The causal proteins for the majority of neurological diseases are not differentially or cross sectionally changed
28:50 The future prospects of serial sampling and what is the potential value vs logistical burden
31:05 Imaging derived phenotypes: Integration of brain scan data with genetics
32:32 How well can brain organoids or other kinds of cellular systems match what’s going on in the actual brain?
35:30 The most exciting developments in the field we might see in the next couple of years
37:45 Closing remarks
Please consider rating and reviewing (https://drive.google.com/file/d/1Bp2_...) us on your chosen podcast listening platform!